Teyi Pharmaceutical Group Co.,ltd
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Teyi Pharmaceutical Group Co., Ltd. (referred to as Teyi Pharmaceutical) is a pharmaceutical listed company (stock code 002728) that integrates pharmaceutical research and development, pharmaceutical industry, and pharmaceutical commerce. Its subsidiaries are distributed in Guangdong, Hainan, Anhui, and other regions. Teyi Pharmaceutical and its wholly-owned subsidiaries Hainan Haili Pharmaceutical Co., Ltd. and Taishan Xinning Pharmaceutical Co., Ltd. are all national high-tech enterprises. Teyi Pharmaceutical has been successively awarded the titles of "Outstanding Contribution Enterprise in the Guangdong Pharmaceutical Industry", "Guangdong Private Science and Technology Enterprise", "2015 Top 10 Comprehensive Strength of Guangdong Pharmaceutical Industry Enterprises", "Guangdong Private Enterprise Innovation Industrialization Demonstration Base", "2018 56th China Top 100 Traditional Chinese Medicine Enterprises", "Guangdong Innovative Enterprise", "Contract abiding and Trustworthy Enterprise", and "A-level Taxpayer" AAA level credit rating customers, Top 100 Taxpaying Enterprises, 2014 Guangdong Province Top 500 Manufacturing Enterprises, etc; Hainan Haili Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Teyi Pharmaceutical, has been successively rated as "2018 National Intellectual Property Advantage Enterprise", "Hainan Pharmaceutical Industry Top Ten Honest Units", "Hainan Industrial Economy Standardization Management Top Ten Benchmark Enterprises", "Hainan Industrial Industry Leading Enterprise (traditional Chinese patent medicines and simple preparations manufacturing industry)", "National Quality, Service, Credit AAA Enterprise" and "A-level Taxpayer". The pharmaceutical industry of Teyi Pharmaceutical includes the Taishan Pharmaceutical Production Base (formerly Taicheng Pharmaceutical, Guangdong), Haikou Pharmaceutical Production Base (Hainan Haili Pharmaceutical Co., Ltd.), Raw Material Pharmaceutical Production Base (Taishan Xinning Pharmaceutical Co., Ltd.), and Chemical Product Production Base (Taishan Chemical Factory Co., Ltd.). The products of Teyi Pharmaceutical Group include traditional Chinese patent medicines and simple preparations, chemical preparations, chemical raw materials and chemical products. Among them, the "Teyi" brand series covers various aspects such as cough relieving and phlegm resolving, kidney tonifying, anti infection, cardiovascular, cerebrovascular, and digestive system medication. Among them, the main preparation products include cough relieving tablets, Pudillan anti-inflammatory tablets, Xuesaitong dispersible tablets, Yixinshu granules, Ginkgo biloba dispersible tablets, Jinguishenqi tablets, magnesium aluminate chewing tablets, erythromycin enteric coated tablets, erythromycin tablets, roxithromycin capsules, amoxicillin capsules Omeprazole enteric coated capsules, etc; The main chemical raw materials and chemical products include magnesium aluminate, sodium phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth series, citric acid series, zinc sulfate, etc. The core product of Teyi Pharmaceutical is Zhike Baopian, which is an exclusive variety in China. Its secret formula was included in the Lingnan Traditional Chinese Medicine Cultural Heritage Protection List (the first batch) in 2009 and was recognized as a key new product in Guangdong Province in 2012; The key products produced by the wholly-owned subsidiary Taishan Xinning Pharmaceutical Co., Ltd. include magnesium aluminate, sodium phenytoin, glacial acetic acid, calcium chloride, and other raw materials, which rank among the top in the national market share. Sodium chloride for injection and bismuth basic nitrate have been awarded the title of "High Quality Product of the National Medical Administration". Teyi Pharmaceutical added pills and eye drops in 2018 through asset acquisition. The main varieties of pills include Skin Disease Blood Poison Pills, Acne Removing Pills, Tongmai Jiangzhi Pills, Ruyi Dingchuan Pills, Wulin Pills, Anti tuberculosis Pills, Menstrual Regulation and Spot Removing Pills, etc. The main products of eye drops include Compound Dextran 70 Eye Drops, etc. At the same time, it also enriches the existing product portfolio, such as Pudi Lan anti-inflammatory tablets, Ganmao Ling granules, Xiqing Guo granules, etc. in the respiratory system, Fengliao Changwei Kang tablets, etc. in the digestive system, Zhuangyao Jianshen pills, Bushen Banlong capsules, etc. in the tonifying category, which has improved the product line segmentation field for Teyi Pharmaceutical and provided guarantee for the segmentation and refined promotion of sales channels. Teyi Pharmaceutical Group currently has two national sales and commercial platforms, among which Guangdong Teyi Haili Pharmaceutical Co., Ltd. operates the "Teyi" brand series produced by Teyi Pharmaceutical Industry. The other business platform is Hainan Haili Doctor Pharmaceutical Group Co., Ltd., which operates OEM products of the "Haili Doctor" brand, and adopts regional exclusive agency sales nationwide, including traditional Chinese patent medicines and simple preparations and chemical preparations. It is also an important support for the development of the diversified and specialized value-added business direction of Teyi Pharmaceutical. In the future, Teyi Pharmaceutical will continue to adhere to the corporate tenet of "focusing on quality, strengthening research and development, and sustainable development", with endogenous growth as the core and external growth as the auxiliary, strengthening resource integration and internal potential tapping, committed to building excellent brands, maintaining sustainable development of the enterprise, and becoming a competitive pharmaceutical enterprise. |
| Headquarter | Jiangmen |
| Establish Date | 5/23/2002 |
| Listed Code | 002728.SZ |
| Listed Date | 7/31/2014 |
| Chairman | Xu Danqing. |
| CEO | Xu Danqing. |
| Website | www.tczy.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
